Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-617-8 | CAS number: 123-31-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Study meets basic scientific principles of an acute toxicity study reporting on mortalities and clinical signs of intoxication occurring within 24 h post application, no information on purity of the test substance, sufficient documentation of test results to be accepted as key study
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 948
- Report date:
- 1948
Materials and methods
- Principles of method if other than guideline:
- Observation of mortalities and clinical signs of intoxication occuring within 24 h after i.p. application of two different grades of HQ
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Hydroquinone
- EC Number:
- 204-617-8
- EC Name:
- Hydroquinone
- Cas Number:
- 123-31-9
- Molecular formula:
- C6H6O2
- IUPAC Name:
- hydroquinone
- Details on test material:
- - Name of test material (as cited in study report): Hydroquinone TEC pure (food grade), Hydroquinone photographic (photo grade)
- Analytical purity: no data
- Batch: no data
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: albino
- Sex:
- male/female
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- water
- Doses:
- 78 - 300 mg/kg bw as 1% solution
- No. of animals per sex per dose:
- 5 for each grade of HQ
- Details on study design:
- - Duration of observation period following administration: 24 h
- Other examinations performed: clinical signs
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 160 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: HQ food grade
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 175 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: HQ photo grade
- Mortality:
- HQ TEC pure: 0% up to 135 mg/kg; 40% at 135 mg/kg (2nd experiment); 40% at 154 mg/kg; 100% at 202 mg/kg; 80% at 225 mg/kg; 60% at 230 and 300 mg/kg; deaths occurred also several hrs p.a.
HQ photo grade: 0% at 81 mg/kg; 40% at 114 and 164 mg/kg; 60% at 210 mg/kg; 100% at 225 mg/kg; 80% at 229 mg/kg; 60% at 263 mg/kg; 80% at 266 and 269 mg/kg; deaths occurred witin 10 to 30 min p.a. - Clinical signs:
- Clonic convulsive movements proceeding into running movements; heart observed to beat for several minutes after respiration ceased
Applicant's summary and conclusion
- Conclusions:
- After intraperitoneal injection LD50 values in the range of 160 or 175 mg/kg bw were found in male or female Albino rats.
- Executive summary:
Mortalities and clinical signs of intoxication were observed in male and female albino rats after i.p.application of two different grades of HQ (food grade and photographic grade) for a total observation period of 24 hrs. In male and female rats, LD50 values were in the range of 160 or 175 mg/kg bw for the food grade and photographic grade, respectively. These values were found to be similar to intraperitoneal LD50 values of other species, as e.g. mice, rabbits, and guinea pigs. Clinical signs were characterized by clonic convulsive movements proceeding into running movements pointing to central nervous system effects.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
